Terms: = Gastric cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Treatment
16 results:
1. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract] [Full Text] [Related]
2. The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
Janczewski LM; Shah D; Wells A; Bentrem DJ; Abad JD; Chawla A
J Surg Oncol; 2023 Jun; 127(7):1116-1124. PubMed ID: 36905333
[TBL] [Abstract] [Full Text] [Related]
3. shp2 inhibition mitigates adaptive resistance to MEK inhibitors in KRAS-mutant gastric cancer through the suppression of KSR1 activity.
Zheng W; Yang Z; Song P; Sun Y; Liu P; Yue L; Lv K; Wang X; Shen Y; Si J; Zhang X; Ke Y; Cheng H; Hu W
Cancer Lett; 2023 Feb; 555():216029. PubMed ID: 36493900
[TBL] [Abstract] [Full Text] [Related]
4. Trastuzumab combined chemotherapy for the treatment of HER2-positive advanced gastric cancer: A systematic review and meta-analysis of randomized controlled trial.
Xue C; Xu YH
Medicine (Baltimore); 2022 Aug; 101(34):e29992. PubMed ID: 36042610
[TBL] [Abstract] [Full Text] [Related]
5. Allosteric Inhibitors of shp2 with Therapeutic Potential for cancer treatment.
Xie J; Si X; Gu S; Wang M; Shen J; Li H; Shen J; Li D; Fang Y; Liu C; Zhu J
J Med Chem; 2017 Dec; 60(24):10205-10219. PubMed ID: 29155585
[TBL] [Abstract] [Full Text] [Related]
6. Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL.
Kuo SH; Chen LT; Lin CW; Yeh KH; Shun CT; Tzeng YS; Liou JM; Wu MS; Hsu PN; Cheng AL
Blood; 2017 Jan; 129(2):188-198. PubMed ID: 27864293
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study.
Tanabe S; Ishido K; Matsumoto T; Kosaka T; Oda I; Suzuki H; Fujisaki J; Ono H; Kawata N; Oyama T; Takahashi A; Doyama H; Kobayashi M; Uedo N; Hamada K; Toyonaga T; Kawara F; Tanaka S; Yoshifuku Y
Gastric Cancer; 2017 Mar; 20(Suppl 1):45-52. PubMed ID: 27807641
[TBL] [Abstract] [Full Text] [Related]
8. Chemotherapy Effectiveness and Prognosis of gastric cancer Influenced by ptpn11 Polymorphisms.
Zhuo C; Shao M; Chen C; Lin C; Jiang D; Chen G; Tian H; Wang L; Li J; Lin X
Cell Physiol Biochem; 2016; 39(4):1537-52. PubMed ID: 27614952
[TBL] [Abstract] [Full Text] [Related]
9. Functions of shp2 in cancer.
Zhang J; Zhang F; Niu R
J Cell Mol Med; 2015 Sep; 19(9):2075-83. PubMed ID: 26088100
[TBL] [Abstract] [Full Text] [Related]
10. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.
Moehler M; Sieben M; Roth S; Springsguth F; Leuchs B; Zeidler M; Dinsart C; Rommelaere J; Galle PR
BMC Cancer; 2011 Oct; 11():464. PubMed ID: 22029859
[TBL] [Abstract] [Full Text] [Related]
11. The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma.
Yoon HJ; Hong JS; Shin WJ; Lee YJ; Hong KO; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Nov; 47(11):1023-31. PubMed ID: 21824804
[TBL] [Abstract] [Full Text] [Related]
12. FGF signaling network in the gastrointestinal tract (review).
Katoh M; Katoh M
Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
[TBL] [Abstract] [Full Text] [Related]
13. [Production and identification of a monoclonal antibody against a tumor associated antigen from ovarian epithelial carcinoma].
Gong GL; Zou JY; Cai ZT
Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):395-7, 443-4. PubMed ID: 8001414
[TBL] [Abstract] [Full Text] [Related]
14. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.
Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K
Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807
[TBL] [Abstract] [Full Text] [Related]
15. A stomach oncofetal antigen recognized by monoclonal antibody GC302.
Watanabe T; Nishikimi M; Akiyama S; Sakamoto J; Shiku H; Ichihashi H; Ozawa T; Kondo T; Takagi H
Jpn J Surg; 1987 Nov; 17(6):507-16. PubMed ID: 3325673
[TBL] [Abstract] [Full Text] [Related]
16. Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3 with specificity for H(O) blood group antigen.
Anger BR; Lloyd KO; Oettgen HF; Old LJ
Hybridoma; 1982; 1(2):139-47. PubMed ID: 6208122
[TBL] [Abstract] [Full Text] [Related]
